[go: up one dir, main page]

GR1000252B - Dose type constituted of quick release of an effective agent - Google Patents

Dose type constituted of quick release of an effective agent

Info

Publication number
GR1000252B
GR1000252B GR880100573A GR880100573A GR1000252B GR 1000252 B GR1000252 B GR 1000252B GR 880100573 A GR880100573 A GR 880100573A GR 880100573 A GR880100573 A GR 880100573A GR 1000252 B GR1000252 B GR 1000252B
Authority
GR
Greece
Prior art keywords
quick release
effective agent
type constituted
dose type
compartment
Prior art date
Application number
GR880100573A
Other languages
Greek (el)
Inventor
Atul Ayer Devdatt
David Emil Edgren
Maureen Jordan
Paul Magruder
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of GR1000252B publication Critical patent/GR1000252B/en

Links

Landscapes

  • Catching Or Destruction (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Αποκαλύπτεται μορφή δοσολογίας που περιβάλει ένα τοίχωμα 12 που περιλαμβάνει ένα διαμέρισμα 15 με ένα μέσο εξόδου 13 σε ένα τοίχωμα 12. Το διαμέρισμα 15 περιλαμβάνει ένα πρώτο ή ταχείας απελευθέρωσης λεπτό φύλλο 16 και ένα δεύτερο ή βραδείας απελευθέρωσης λεπτό φύλλο 17, που απελευθερώνονται μέσω του μέσου εξόδου σε δύο διαφορετικές περιόδους χρόνου. Τουλάχιστον ένα από τα λεπτα φύλλα 16 ή 17 περιέχει ένα φάρμακο που απελευθερώνεται μέσω του μέσου εξόδου 13. ωA dosage form is disclosed which surrounds a wall 12 that includes a compartment 15 with an outlet means 13 in a wall 12. The compartment 15 includes a first or rapid release foil 16 and a second or slow release foil 17, which are released through the means output in two different time periods. At least one of the foils 16 or 17 contains a drug that is released through the outlet means 13. o

GR880100573A 1988-09-02 1988-09-02 Dose type constituted of quick release of an effective agent GR1000252B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR88100573 1988-09-02

Publications (1)

Publication Number Publication Date
GR1000252B true GR1000252B (en) 1992-05-12

Family

ID=10938834

Family Applications (1)

Application Number Title Priority Date Filing Date
GR880100573A GR1000252B (en) 1988-09-02 1988-09-02 Dose type constituted of quick release of an effective agent

Country Status (1)

Country Link
GR (1) GR1000252B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135880A (en) * 1983-03-04 1984-09-12 Alza Corp Osmotic drug delivery device
GB2167972A (en) * 1984-12-06 1986-06-11 Alza Corp Dispensing device
WO1987000044A1 (en) * 1985-07-02 1987-01-15 The Upjohn Company Therapeutic formulations with bimodal release characteristics
GB2189995A (en) * 1986-05-09 1987-11-11 Alza Corp Dosage dispenser containing osmotic solute and hydrogel

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2135880A (en) * 1983-03-04 1984-09-12 Alza Corp Osmotic drug delivery device
GB2167972A (en) * 1984-12-06 1986-06-11 Alza Corp Dispensing device
WO1987000044A1 (en) * 1985-07-02 1987-01-15 The Upjohn Company Therapeutic formulations with bimodal release characteristics
GB2189995A (en) * 1986-05-09 1987-11-11 Alza Corp Dosage dispenser containing osmotic solute and hydrogel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CLAIMS SEARCHED: ALL *

Similar Documents

Publication Publication Date Title
MX9202934A (en) DERIVATIVES OF CARBOSTIRILE AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
ATE63689T1 (en) PHARMACEUTICAL COMPOSITION.
IT8819179A0 (en) HEMODIAFILTRATION DEVICE AND RELATED HEMODIAFILTRATION PROCEDURE.
IT1147315B (en) GELDANAMYCIN DERIVATIVES AND ANTI-CANCER DRUGS
FI891481L (en) CRYMP FOIL.
FI893340A0 (en) FOERFARANDE FOER ATT ERHAOLLA PHARMACEUTICAL SAMMANSAETTNINGAR FOER ATT HINDRA SMITTBARA KOENSSJUKDOMAR.
NL190605C (en) Foil with at least three layers.
DE68926923D1 (en) Microwave ion source
ES2087237T3 (en) PROGESTOGEN AS A SOLE CONTRACEPTIVE.
NO882653D0 (en) DOSAGE FORM.
DE68907121D1 (en) ACCELERATOR.
DE68900126D1 (en) VINYLAROMATIC CONNECTIONS STABILIZED AGAINST POLYMERIZATION.
FI893835L (en) MEDICINE
FI896012A7 (en) Device for the study of objects based on acoustic emission
IT8019740A0 (en) BENZOAZEPINE DERIVATIVES.
DE68904973D1 (en) EXPLOSIVE DETECTOR SYSTEM.
IT8920345A0 (en) DIVIDER DEVICE.
GR1000252B (en) Dose type constituted of quick release of an effective agent
MX14512A (en) PHOTOPOLYMERIZABLE COMPOSITION AND ARTICLE THAT INCLUDES THE COMPOSITION.
MX9203613A (en) DERIVATIVES OF ADENOSINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
DE68914420D1 (en) Synchrotron radiation device.
FR2346339A1 (en) BENZOGUANAMINE DERIVATIVES AND THEIR PHARMACEUTICAL USES, ESPECIALLY AS ANTIPHLOGISTIC AGENTS AND DEPRESSING THE CENTRAL NERVOUS SYSTEM
FI891464A0 (en) HASTIGHETSENHET FOER INVERTER.
ES2072869T3 (en) USE OF 1,4-DIHYDROPYRIDINE DERIVATIVES IN THE TREATMENT OF ALCOHOLISM.
DE68911779D1 (en) Electron synchrotron acceleration system.